BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24907006)

  • 1. [Stereotactic ablative irradiation for lung cancer].
    Antoni D; Srour I; Noël G; Mornex F
    Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung cancer: Stereotactic body radiation therapy and surgery].
    Antoni D; Srour I; Mornex F
    Cancer Radiother; 2015 Oct; 19(6-7):371-6. PubMed ID: 26358983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery?].
    Kaiss H; Mornex F
    Cancer Radiother; 2019 Oct; 23(6-7):720-731. PubMed ID: 31471255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stereotactic radiotherapy for pelvic tumors].
    Mazeron R; Fumagalli I
    Cancer Radiother; 2014; 18(4):325-31. PubMed ID: 24792995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy for primary lung carcinoma].
    Giraud P; Lacornerie T; Mornex F
    Cancer Radiother; 2016 Sep; 20 Suppl():S147-56. PubMed ID: 27516052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy for intrathoracic metastases].
    Giraud P; Lacornerie T; Mornex F
    Cancer Radiother; 2016 Sep; 20 Suppl():S157-60. PubMed ID: 27523413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic tumors and radiotherapy].
    Rio E; Mornex F; Peiffert D; Huertas A
    Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
    De Bari B; Filippi AR; Mazzola R; Bonomo P; Trovò M; Livi L; Alongi F
    Cancer Treat Rev; 2015 Jun; 41(6):511-8. PubMed ID: 25913714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oligometastatic disease, a new concept: stereotactic irradiation for lung metastases. Literature review].
    Hatime M; Elmorabit B; Elkhoti Y; Touch S; Tanguy R; Mornex F
    Cancer Radiother; 2012 Sep; 16(5-6):351-7. PubMed ID: 22921980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
    Timmerman RD; Fernando HC
    Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stereotactic body radiotherapy. How to better protect normal tissues?].
    Pasquier D; Lacornerie T; Mirabel X; Brassart C; Vanquin L; Lartigau E
    Cancer Radiother; 2019 Oct; 23(6-7):630-635. PubMed ID: 31447339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delineation of organs at risk and dose constraints].
    Noël G; Antoni D; Barillot I; Chauvet B
    Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stereotactic body radiation therapy and oligometastases].
    Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
    Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyberknife radiotherapy for vestibular schwannoma.
    Sakamoto GT; Blevins N; Gibbs IC
    Otolaryngol Clin North Am; 2009 Aug; 42(4):665-75. PubMed ID: 19751871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.
    Takeda A; Sanuki N; Eriguchi T; Enomoto T; Yokosuka T; Kaneko T; Handa H; Aoki Y; Oku Y; Kunieda E
    Ann Thorac Surg; 2013 Nov; 96(5):1776-82. PubMed ID: 23998410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
    Tsang MW; Kam MK; Leung SF; Chan AT
    Hong Kong Med J; 2014 Dec; 20(6):529-36. PubMed ID: 25256817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
    Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
    Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.